Cocaine augments neuro-inflammation via modulating extracellular vesicle release in HIV-1 infected immune cells

Retrovirology. 2021 Sep 16;18(1):26. doi: 10.1186/s12977-021-00570-4.

Abstract

Background: Extracellular Vesicles (EV) recently have been implicated in the pathogenesis of HIV-1 syndromes, including neuroinflammation and HIV-1 associated neurological disorder (HAND). Cocaine, an illicit stimulant drug used worldwide is known to exacerbate these HIV-1 associated neurological syndromes. However, the effects of cocaine on EV biogenesis and roles of EVs in enhancing HIV-1 pathogenesis are not yet well defined.

Results: Here, we investigated the effects of cocaine on EV biogenesis and release in HIV-1 infected immune cells and explored their roles in elicitation of neuroinflammation. We found that cocaine significantly augmented the release of EVs from uninfected and HIV-1 infected T-cells, DCs and macrophages. Further analysis of the molecular components of EVs revealed enhanced expression of adhesion molecules integrin β1 and LFA-1 in those EVs derived from cocaine treated cells. Intriguingly, in EVs derived from HIV-1 infected cells, cocaine treatment significantly increased the levels of viral genes in EVs released from macrophages and DCs, but not in T-cells. Exploring the molecular mechanism to account for this, we found that DCs and macrophages showed enhanced expression of the cocaine receptor Sigma 1-Receptor compared to T-cells. In addition, we found that cocaine significantly altered the integrity of the RNA-induced silencing complex (RISC) in HIV-1 infected macrophages and DCs compared to untreated HIV-1 infected cells. Characterizing further the molecular mechanisms involved in how cocaine increased EV release, we found that cocaine decreased the expression of the interferon-inducible protein BST-2; this resulted in altered trafficking of intracellular virus containing vesicles and EV biogenesis and release. We also observed EVs released from cocaine treated HIV-1 infected macrophages and DCs enhanced HIV-1 trans-infection to T-cells compared to those from untreated and HIV-1 infected cells. These EVs triggered release of proinflammatory cytokines in human brain microvascular endothelial cells (HBMECs) and altered monolayer integrity.

Conclusions: Taken together, our results provide a novel mechanism which helps to elucidate the enhanced prevalence of neurological disorders in cocaine using HIV-1 infected individuals and offers insights into developing novel therapeutic strategies against HAND in these hosts.

Keywords: Cocaine; Extracellular vesicles; HIV-1; Macrophages; Neuroinflammation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Brain / cytology
  • Cocaine / adverse effects*
  • Cocaine / immunology*
  • Cocaine / pharmacology
  • Cytokines / immunology
  • Dendritic Cells / drug effects*
  • Dendritic Cells / virology
  • Endothelial Cells / drug effects
  • Endothelial Cells / immunology
  • Endothelial Cells / virology
  • Extracellular Vesicles / drug effects*
  • Extracellular Vesicles / immunology
  • Extracellular Vesicles / virology
  • HIV-1 / drug effects
  • HIV-1 / immunology*
  • HIV-1 / pathogenicity
  • Humans
  • Inflammation
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Macrophages / virology
  • Neuroinflammatory Diseases / complications*
  • Organelle Biogenesis

Substances

  • Cytokines
  • Cocaine